ULTRAGENYX PHARMACEUTICAL INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2012 | — | $-27.0M | $86.2M |
| FY2013 | — | $-74.8M | $7.4M |
| FY2014 | — | $184.9M | $24.3M |
| FY2015 | — | $531.1M | $93.6M |
| FY2016 | — | $474.0M | $161.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2012 | — | $-27.0M | $86.2M |
| FY2013 | — | $-74.8M | $7.4M |
| FY2014 | — | $184.9M | $24.3M |
| FY2015 | — | $531.1M | $93.6M |
| FY2016 | — | $474.0M | $161.1M |